³Ô¹Ï²»´òìÈ

President Trump is searching for a health care victory ahead of the 2020 election, and has turned to executive action to try to achieve it. The administration is looking to fend off attacks from Democrats, who see the president as particularly vulnerable on health care. Trump's coronavirus response has put him on the defensive. (Weixel, 8/22)

Drug makers and their lobbyists are struggling to agree on a strategy that would convince President Trump to back off a highly controversial drug pricing policy that he vowed to enact on Monday. This week, the group, the Pharmaceutical Research and Manufacturers of America convened three calls with member companies to discuss how to respond to an ultimatum that Trump laid out in July. (Florko and Facher, 8/21)